Skip to main content
Neal Young, MD, Hematology, Bethesda, MD

Neal Stuart Young MD


Chief, Hematology Branch, NHLBI

Join to view full profile
  • Rockville Pike# 10Bethesda, MD 20892

  • Phone+1 301-496-5093

Dr. Young is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1971 - 1973
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1971

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 1978 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1985
  • Member American Association of Physicians

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Outcomes in Pediatric Patients with Severe Aplastic Anemia Treated with Standard Immunosuppression and Eltrombopag
    Neal S. Young, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Analysis of Deficiency of Adenosine Deaminase 2 Pathogenesis Based on Single Cell RNA Sequencing of Monocytes
    Neal S. Young, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Deficit of Circulating CD19+CD24hiCD38hi Regulatory B Cells in Severe Aplastic Anemia
    Neal S. Young, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Bone Marrow Failure: Fanconi Anemia and Aplastic Anemia 
    60th American Society of Hematology Annual Meeting - 12/3/2018
  • Eltrombopag Improves Hematopoiesis in Patients with Low to Intermediate-2 Risk Myelodysplastic Syndrome(MDS) 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Mutations and Manifestations: What’s Known About VEXAS
    Mutations and Manifestations: What’s Known About VEXASAugust 16th, 2024

Grant Support

  • Viruses And HematopoiesisNational Heart, Lung, And Blood Institute2010–2011
  • MyelodysplasiaNational Heart, Lung, And Blood Institute2010–2011
  • Pathogenesis And Treatment Of Aplastic AnemiaNational Heart, Lung, And Blood Institute1990–2008
  • Viruses And HematopoeiesisNational Heart, Lung, And Blood Institute1996–1997
  • B19 Parvovirus And Adeno-Associated VirusNational Heart, Lung, And Blood Institute1994–1995

Professional Memberships

Other Languages

  • Italian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: